China's first mortar ribonucleic acid (MRNA) coronary vaccine has been included in China to strengthen the priority of coronary immunity.
The official website of the China Health and Health Commission published on Monday (April 10) published a work plan for the vaccination of the crown disease epidemic vaccine, announcing the MRNA vaccine of the Stone Medicine Group, as well as the metaphysics of the Cross -Valid Symptom Syrine S.The vaccine has been included in emergency use and can be used for people over 18 years old to strengthen immunization.
According to this solution, in terms of vaccines used in the basic immunization of the target population, refer to the relevant requirements of the early stage, strengthen the use of these two vaccines to strengthen immunity.Listing, or incorporated urgently use reorganized protein vaccine or virus vector vaccine for sequentially enhanced immune vaccination.
People over 18 years of age who have been infected and failed to complete basic immunity, prioritize the use of vaccines of Shenzhou cells and stone medicine group vaccination, or choose other reorganized proteins that have been approved to be listed or incorporated into emergency use,Vaccine or virus vector vaccination.
